90 related articles for article (PubMed ID: 35283010)
41. Very Early Recurrence After Liver Resection for Intrahepatic Cholangiocarcinoma: Considering Alternative Treatment Approaches.
Tsilimigras DI; Sahara K; Wu L; Moris D; Bagante F; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Soubrane O; Koerkamp BG; Moro A; Sasaki K; Aucejo F; Zhang XF; Matsuyama R; Endo I; Pawlik TM
JAMA Surg; 2020 Sep; 155(9):823-831. PubMed ID: 32639548
[TBL] [Abstract][Full Text] [Related]
42. The Evolutionary Origins of Recurrent Pancreatic Cancer.
Sakamoto H; Attiyeh MA; Gerold JM; Makohon-Moore AP; Hayashi A; Hong J; Kappagantula R; Zhang L; Melchor JP; Reiter JG; Heyde A; Bielski CM; Penson AV; Gönen M; Chakravarty D; O'Reilly EM; Wood LD; Hruban RH; Nowak MA; Socci ND; Taylor BS; Iacobuzio-Donahue CA
Cancer Discov; 2020 Jun; 10(6):792-805. PubMed ID: 32193223
[TBL] [Abstract][Full Text] [Related]
43. Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer.
Zheng X; Yao Z; Huang Y; Yu Y; Wang Y; Liu Y; Mao R; Li F; Xiao Y; Wang Y; Hu Y; Yu J; Zhou J
Nat Commun; 2020 Mar; 11(1):1236. PubMed ID: 32144248
[TBL] [Abstract][Full Text] [Related]
44. Tumour heterogeneity revealed by unsupervised decomposition of dynamic contrast-enhanced magnetic resonance imaging is associated with underlying gene expression patterns and poor survival in breast cancer patients.
Fan M; Xia P; Liu B; Zhang L; Wang Y; Gao X; Li L
Breast Cancer Res; 2019 Oct; 21(1):112. PubMed ID: 31623683
[TBL] [Abstract][Full Text] [Related]
45. Intrahepatic cholangiocarcinoma tumor burden: A classification and regression tree model to define prognostic groups after resection.
Bagante F; Spolverato G; Merath K; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Endo I; Pawlik TM
Surgery; 2019 Dec; 166(6):983-990. PubMed ID: 31326191
[TBL] [Abstract][Full Text] [Related]
46. Prediction for early recurrence of intrahepatic mass-forming cholangiocarcinoma: quantitative magnetic resonance imaging combined with prognostic immunohistochemical markers.
Zhao L; Ma X; Liang M; Li D; Ma P; Wang S; Wu Z; Zhao X
Cancer Imaging; 2019 Jul; 19(1):49. PubMed ID: 31307551
[TBL] [Abstract][Full Text] [Related]
47. Advanced Intrahepatic Cholangiocarcinoma: Post Hoc Analysis of the ABC-01, -02, and -03 Clinical Trials.
Lamarca A; Ross P; Wasan HS; Hubner RA; McNamara MG; Lopes A; Manoharan P; Palmer D; Bridgewater J; Valle JW
J Natl Cancer Inst; 2020 Feb; 112(2):200-210. PubMed ID: 31077311
[TBL] [Abstract][Full Text] [Related]
48. Survival after Resection of Multiple Tumor Foci of Intrahepatic Cholangiocarcinoma.
Buettner S; Ten Cate DWG; Bagante F; Alexandrescu S; Marques HP; Lamelas J; Aldrighetti L; Gamblin TC; Maithel SK; Pulitano C; Margonis GA; Weiss M; Bauer TW; Shen F; Poultsides GA; Marsh JW; IJzermans JNM; Pawlik TM; Koerkamp BG
J Gastrointest Surg; 2019 Nov; 23(11):2239-2246. PubMed ID: 30887301
[TBL] [Abstract][Full Text] [Related]
49. Novel Nomogram for Preoperative Prediction of Early Recurrence in Intrahepatic Cholangiocarcinoma.
Liang W; Xu L; Yang P; Zhang L; Wan D; Huang Q; Niu T; Chen F
Front Oncol; 2018; 8():360. PubMed ID: 30234019
[No Abstract] [Full Text] [Related]
50. CT radiomics to predict high-risk intraductal papillary mucinous neoplasms of the pancreas.
Chakraborty J; Midya A; Gazit L; Attiyeh M; Langdon-Embry L; Allen PJ; Do RKG; Simpson AL
Med Phys; 2018 Nov; 45(11):5019-5029. PubMed ID: 30176047
[TBL] [Abstract][Full Text] [Related]
51. Preoperative risk prediction for intraductal papillary mucinous neoplasms by quantitative CT image analysis.
Attiyeh MA; Chakraborty J; Gazit L; Langdon-Embry L; Gonen M; Balachandran VP; D'Angelica MI; DeMatteo RP; Jarnagin WR; Kingham TP; Allen PJ; Do RK; Simpson AL
HPB (Oxford); 2019 Feb; 21(2):212-218. PubMed ID: 30097414
[TBL] [Abstract][Full Text] [Related]
52. Patterns of Distribution of Hepatic Nodules (Single, Satellites or Multifocal) in Intrahepatic Cholangiocarcinoma: Prognostic Impact After Surgery.
Conci S; Ruzzenente A; Viganò L; Ercolani G; Fontana A; Bagante F; Bertuzzo F; Dore A; Pinna AD; Torzilli G; Iacono C; Guglielmi A
Ann Surg Oncol; 2018 Nov; 25(12):3719-3727. PubMed ID: 30088126
[TBL] [Abstract][Full Text] [Related]
53. Development and Validation of an MRI-Based Radiomics Signature for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer.
Wu S; Zheng J; Li Y; Wu Z; Shi S; Huang M; Yu H; Dong W; Huang J; Lin T
EBioMedicine; 2018 Aug; 34():76-84. PubMed ID: 30078735
[TBL] [Abstract][Full Text] [Related]
54. Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention.
Lowery MA; Ptashkin R; Jordan E; Berger MF; Zehir A; Capanu M; Kemeny NE; O'Reilly EM; El-Dika I; Jarnagin WR; Harding JJ; D'Angelica MI; Cercek A; Hechtman JF; Solit DB; Schultz N; Hyman DM; Klimstra DS; Saltz LB; Abou-Alfa GK
Clin Cancer Res; 2018 Sep; 24(17):4154-4161. PubMed ID: 29848569
[No Abstract] [Full Text] [Related]
55. Short-term reproducibility of radiomic features in liver parenchyma and liver malignancies on contrast-enhanced CT imaging.
Perrin T; Midya A; Yamashita R; Chakraborty J; Saidon T; Jarnagin WR; Gonen M; Simpson AL; Do RKG
Abdom Radiol (NY); 2018 Dec; 43(12):3271-3278. PubMed ID: 29730738
[TBL] [Abstract][Full Text] [Related]
56. Intrahepatic cholangiocarcinoma: can imaging phenotypes predict survival and tumor genetics?
Aherne EA; Pak LM; Goldman DA; Gonen M; Jarnagin WR; Simpson AL; Do RK
Abdom Radiol (NY); 2018 Oct; 43(10):2665-2672. PubMed ID: 29492607
[TBL] [Abstract][Full Text] [Related]
57. Survival Prediction in Pancreatic Ductal Adenocarcinoma by Quantitative Computed Tomography Image Analysis.
Attiyeh MA; Chakraborty J; Doussot A; Langdon-Embry L; Mainarich S; Gönen M; Balachandran VP; D'Angelica MI; DeMatteo RP; Jarnagin WR; Kingham TP; Allen PJ; Simpson AL; Do RK
Ann Surg Oncol; 2018 Apr; 25(4):1034-1042. PubMed ID: 29380093
[TBL] [Abstract][Full Text] [Related]
58. Outcomes of resection for solitary ≤5 cm intrahepatic cholangiocarcinoma.
Tarchi P; Tabrizian P; Prigoff J; Schwartz M
Surgery; 2018 Apr; 163(4):698-702. PubMed ID: 29277385
[TBL] [Abstract][Full Text] [Related]
59. Preliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patients.
Chakraborty J; Langdon-Embry L; Cunanan KM; Escalon JG; Allen PJ; Lowery MA; O'Reilly EM; Gönen M; Do RG; Simpson AL
PLoS One; 2017; 12(12):e0188022. PubMed ID: 29216209
[TBL] [Abstract][Full Text] [Related]
60. Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent.
Zhang XF; Beal EW; Bagante F; Chakedis J; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Pawlik TM
Br J Surg; 2018 Jun; 105(7):848-856. PubMed ID: 29193010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
